메뉴 건너뛰기




Volumn 8, Issue 1, 2011, Pages 42-49

Contemporary management of low-risk bladder cancer

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; GEMCITABINE; MITOMYCIN C; PIRARUBICIN; PLACEBO; THIOTEPA;

EID: 78651355497     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2010.208     Document Type: Review
Times cited : (25)

References (94)
  • 1
    • 67349258581 scopus 로고    scopus 로고
    • The present and future burden of urinary bladder cancer in the world
    • Ploeg, M., Aben, K. K. & Kiemeney, L. A. The present and future burden of urinary bladder cancer in the world. World J. Urol. 27, 289-293 (2009).
    • (2009) World J. Urol. , vol.27 , pp. 289-293
    • Ploeg, M.1    Aben, K.K.2    Kiemeney, L.A.3
  • 3
    • 0346100499 scopus 로고    scopus 로고
    • The health economics of bladder cancer: A comprehensive review of the published literature
    • Botteman, M. F., Pashos, C. L., Redaelli, A., Laskin, B. & Hauser, R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 21, 1315-1330 (2003).
    • (2003) Pharmacoeconomics , vol.21 , pp. 1315-1330
    • Botteman, M.F.1    Pashos, C.L.2    Redaelli, A.3    Laskin, B.4    Hauser, R.5
  • 4
    • 33748925553 scopus 로고    scopus 로고
    • Clinical model of lifetime cost of treating bladder cancer and associated complications
    • Avritscher, E. B. et al. Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology 68, 549-553 (2006).
    • (2006) Urology , vol.68 , pp. 549-553
    • Avritscher, E.B.1
  • 5
    • 45849140589 scopus 로고    scopus 로고
    • EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder
    • Babjuk, M. et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur. Urol. 54, 303-314 (2008).
    • (2008) Eur. Urol. , vol.54 , pp. 303-314
    • Babjuk, M.1
  • 6
    • 32944465832 scopus 로고    scopus 로고
    • Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
    • Sylvester, R. J. et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 49, 466-477 (2006).
    • (2006) Eur. Urol. , vol.49 , pp. 466-477
    • Sylvester, R.J.1
  • 7
    • 67651092245 scopus 로고    scopus 로고
    • Recurrence and progression of disease in non-muscle-invasive bladder cancer: From epidemiology to treatment strategy
    • Van Rhijn, B. W. et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur. Urol. 56, 430-442 (2009).
    • (2009) Eur. Urol. , vol.56 , pp. 430-442
    • Van Rhijn, B.W.1
  • 8
    • 36049006136 scopus 로고    scopus 로고
    • Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
    • Hall, M. C. et al. Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update. J. Urol. 178, 2314-2330 (2007).
    • (2007) J. Urol. , vol.178 , pp. 2314-2330
    • Hall, M.C.1
  • 9
    • 5144224183 scopus 로고    scopus 로고
    • Focus on bladder cancer
    • Dinney, C. P et al. Focus on bladder cancer. Cancer Cell 6, 111-116 (2004).
    • (2004) Cancer Cell , vol.6 , pp. 111-116
    • Dinney, C.P.1
  • 10
    • 33644868287 scopus 로고    scopus 로고
    • Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
    • Knowles, M. A. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 27, 361-373 (2006).
    • (2006) Carcinogenesis , vol.27 , pp. 361-373
    • Knowles, M.A.1
  • 11
    • 49749100700 scopus 로고    scopus 로고
    • Molecular pathogenesis of bladder cancer
    • Knowles, M. A. Molecular pathogenesis of bladder cancer. Int. J. Clin. Oncol. 13, 287-297 (2008).
    • (2008) Int. J. Clin. Oncol. , vol.13 , pp. 287-297
    • Knowles, M.A.1
  • 12
    • 77953847133 scopus 로고    scopus 로고
    • Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression
    • McConkey, D. J. et al. Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression. Urol. Oncol. 28, 429-440 (2010).
    • (2010) Urol. Oncol. , vol.28 , pp. 429-440
    • McConkey, D.J.1
  • 13
    • 34247337239 scopus 로고    scopus 로고
    • Molecular pathways in invasive bladder cancer: New insights into mechanisms, progression, and target identification
    • Mitra, A. P, Datar, R. H. & Cote, R. J. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J. Clin. Oncol. 24, 5552-5564 (2006).
    • (2006) J. Clin. Oncol. , vol.24 , pp. 5552-5564
    • Mitra, A.P.1    Datar, R.H.2    Cote, R.J.3
  • 14
    • 25444467767 scopus 로고    scopus 로고
    • Urothelial tumorigenesis: A tale of divergent pathways
    • Wu, X. R. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev. Cancer 5, 713-725 (2005).
    • (2005) Nat Rev. Cancer , vol.5 , pp. 713-725
    • Wu, X.R.1
  • 15
    • 76649100093 scopus 로고    scopus 로고
    • Biology of urothelial tumorigenesis: Insights from genetically engineered mice
    • Wu, X. R. Biology of urothelial tumorigenesis: insights from genetically engineered mice. Cancer Metastasis Rev. 28, 281-290 (2009).
    • (2009) Cancer Metastasis Rev. , vol.28 , pp. 281-290
    • Wu, X.R.1
  • 16
    • 0032521376 scopus 로고    scopus 로고
    • Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53
    • Cote, R. J. et al. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res. 58, 1090-1094 (1998).
    • (1998) Cancer Res. , vol.58 , pp. 1090-1094
    • Cote, R.J.1
  • 17
    • 0025782858 scopus 로고
    • Identification of p53 gene mutations in bladder cancers and urine samples
    • Sidransky, D. et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 252, 706-709 (1991).
    • (1991) Science , vol.252 , pp. 706-709
    • Sidransky, D.1
  • 19
    • 73749086073 scopus 로고    scopus 로고
    • Urothelial dysplasia and other flat lesions of the urinary bladder: Clinicopathologic and molecular features
    • Hodges, K. B., Lopez-Beltran, A., Davidson, D. D., Montironi, R. & Cheng, L. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features. Hum. Pathol. 41 155-162 (2010).
    • (2010) Hum. Pathol. , vol.41 , pp. 155-162
    • Hodges, K.B.1    Lopez-Beltran, A.2    Davidson, D.D.3    Montironi, R.4    Cheng, L.5
  • 20
    • 0026467220 scopus 로고
    • Concurrent mutations of coding and regulatory sequences of the Ha-Ras gene in urinary bladder sarcinomas
    • Czerniak, B. et al. Concurrent mutations of coding and regulatory sequences of the Ha-Ras gene in urinary bladder sarcinomas. Hum. Pathol. 23, 1199-1204 (1992).
    • (1992) Hum. Pathol. , vol.23 , pp. 1199-1204
    • Czerniak, B.1
  • 21
    • 0020458159 scopus 로고
    • Localization of the normal allele of T24 human bladder carcinoma oncogene to chromosome 11
    • Mcbride, O. W. et al. Localization of the normal allele of T24 human bladder carcinoma oncogene to chromosome 11. Nature 300, 773-774 (1982).
    • (1982) Nature , vol.300 , pp. 773-774
    • McBride, O.W.1
  • 22
    • 13444279152 scopus 로고    scopus 로고
    • Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: Contribution of exogenous versus endogenous carcinogens
    • Wallerand, H. et al. Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens. Carcinogenesis 26, 177-184 (2005).
    • (2005) Carcinogenesis , vol.26 , pp. 177-184
    • Wallerand, H.1
  • 23
    • 0038011950 scopus 로고    scopus 로고
    • Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome
    • Van Rhijn, B. W. et al. Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome. J. Clin. Oncol. 21, 1912-1921 (2003).
    • (2003) J. Clin. Oncol. , vol.21 , pp. 1912-1921
    • Van Rhijn, B.W.1
  • 24
    • 36248943079 scopus 로고    scopus 로고
    • Role of FGFR3 in urothelial cel carcinoma: Biomarker and potential therapeutic target
    • Knowles, M. A. Role of FGFR3 in urothelial cel carcinoma: biomarker and potential therapeutic target. World J. Urol. 25, 581-593 (2007).
    • (2007) World J. Urol. , vol.25 , pp. 581-593
    • Knowles, M.A.1
  • 25
    • 19944426549 scopus 로고    scopus 로고
    • Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cel growth
    • Gómez-Román, J. J. et al. Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cel growth. Clin. Cancer Res. 11, 459-465 (2005).
    • (2005) Clin. Cancer Res. , vol.11 , pp. 459-465
    • Gómez-Román, J.J.1
  • 26
    • 34249775289 scopus 로고    scopus 로고
    • FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours
    • Van Oers, J. M. et al. FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. Eur. Urol. 52, 760-768 (2007).
    • (2007) Eur. Urol. , vol.52 , pp. 760-768
    • Van Oers, J.M.1
  • 27
    • 33747079040 scopus 로고    scopus 로고
    • Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas
    • Hernández, S. et al. Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. J. Clin. Oncol. 24, 3664-3671 (2006).
    • (2006) J. Clin. Oncol. , vol.24 , pp. 3664-3671
    • Hernández, S.1
  • 28
    • 77955508884 scopus 로고    scopus 로고
    • Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer
    • Van Rhijn, B. W. G. et al. Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer. Eur. Urol. 58, 433-441 (2010).
    • (2010) Eur. Urol. , vol.58 , pp. 433-441
    • Van Rhijn, B.W.G.1
  • 29
    • 33747873545 scopus 로고    scopus 로고
    • PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors
    • López-Knowles, E. et al. PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. Cancer Res. 66, 7401-7404 (2006).
    • (2006) Cancer Res. , vol.66 , pp. 7401-7404
    • López-Knowles, E.1
  • 30
    • 23444440484 scopus 로고    scopus 로고
    • FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma
    • Jebar, A. H. et al. FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. Oncogene 24, 5218-5225 (2005).
    • (2005) Oncogene , vol.24 , pp. 5218-5225
    • Jebar, A.H.1
  • 31
    • 34548407864 scopus 로고    scopus 로고
    • FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer
    • Tomlinson, D. C., Baldo, O., Hamden, P & Knowles, M. A. FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer. J. Pathol. 213, 91-98 (2007).
    • (2007) J. Pathol. , vol.213 , pp. 91-98
    • Tomlinson, D.C.1    Baldo, O.2    Hamden, P.3    Knowles, M.A.4
  • 32
    • 0027183353 scopus 로고
    • Role of chromosome 9 in human bladder cancer
    • Miyao, N. et al. Role of chromosome 9 in human bladder cancer. Cancer Res. 53, 4066-4070 (1993).
    • (1993) Cancer Res. , vol.53 , pp. 4066-4070
    • Miyao, N.1
  • 33
    • 0033521885 scopus 로고    scopus 로고
    • Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: Mplications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer
    • Czerniak, B. et al. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: mplications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. Oncogene 18, 1185-1196 (1999).
    • (1999) Oncogene , vol.18 , pp. 1185-1196
    • Czerniak, B.1
  • 34
    • 0037734062 scopus 로고    scopus 로고
    • Bladder neoplasms\regions at chromosome 9 with putative tumour suppressor genes
    • Wada, T. et al. Bladder neoplasms\regions at chromosome 9 with putative tumour suppressor genes. Scand. J. Urol. Nephrol. 37, 106-111 (2003).
    • (2003) Scand. J. Urol. Nephrol. , vol.37 , pp. 106-111
    • Wada, T.1
  • 35
    • 0034353139 scopus 로고    scopus 로고
    • Epidemiology and etiology of premalignant and malignant urothelial changes
    • Cohen, S. M., Shirai, T. & Steineck, G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand. J. Urol. Nephrol. Suppl. 34, 105-115 (2000).
    • (2000) Scand. J. Urol. Nephrol. Suppl. , vol.34 , pp. 105-115
    • Cohen, S.M.1    Shirai, T.2    Steineck, G.3
  • 36
    • 3042809910 scopus 로고    scopus 로고
    • The association between smoking, beverage consumption, diet and bladder cancer: A systematic literature review
    • Zeegers, M. P, Kellen, E., Buntinx, F & van den Brandt, P A. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J. Urol. 21, 392-401 (2004).
    • (2004) World J. Urol. , vol.21 , pp. 392-401
    • Zeegers, M.P.1    Kellen, E.2    Buntinx, F.3    Van Den Brandt, P.A.4
  • 37
    • 0019514110 scopus 로고
    • International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/3: Carcinogens and carcinogenesis enhancers
    • Clayson, D. B. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/3: carcinogens and carcinogenesis enhancers. Mutat Res. 86, 217-229 (1981).
    • (1981) Mutat Res. , vol.86 , pp. 217-229
    • Clayson, D.B.1
  • 38
    • 0031474795 scopus 로고    scopus 로고
    • Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines
    • Yasunaga, Y. et al. Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines. Lab. Invest 77, 677-684 (1997).
    • (1997) Lab. Invest , vol.77 , pp. 677-684
    • Yasunaga, Y.1
  • 39
    • 14844320585 scopus 로고    scopus 로고
    • Personal use of hair dyes and the risk of bladder cancer: Results of a meta-analysis
    • Huncharek, M. & Kupelnick, B. Personal use of hair dyes and the risk of bladder cancer: results of a meta-analysis. Public Health Rep. 120, 31-38 (2005).
    • (2005) Public Health Rep. , vol.120 , pp. 31-38
    • Huncharek, M.1    Kupelnick, B.2
  • 40
    • 0021255603 scopus 로고
    • Urinary tract infection and risk of bladder cancer
    • Kantor, A. F et al. Urinary tract infection and risk of bladder cancer. Am. J. Epidemiol. 119, 510-515 (1984).
    • (1984) Am. J. Epidemiol. , vol.119 , pp. 510-515
    • Kantor, A.F.1
  • 42
    • 55049112064 scopus 로고    scopus 로고
    • Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
    • Kiemeney, L. A. et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet. 40, 1307-1312 (2008).
    • (2008) Nat Genet. , vol.40 , pp. 1307-1312
    • Kiemeney, L.A.1
  • 43
    • 69349100058 scopus 로고    scopus 로고
    • Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer
    • Wu, X. et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet. 41, 991-995 (2009).
    • (2009) Nat Genet. , vol.41 , pp. 991-995
    • Wu, X.1
  • 44
    • 59149091340 scopus 로고    scopus 로고
    • Sequence variants at the TERT-CLPTM1L locus associate with many cancer types
    • Rafnar, T. et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet. 41, 221-227 (2009).
    • (2009) Nat Genet. , vol.41 , pp. 221-227
    • Rafnar, T.1
  • 45
    • 77951769462 scopus 로고    scopus 로고
    • A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer
    • Kiemeney, L. A. et al. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet. 42, 415-419 (2010).
    • (2010) Nat Genet. , vol.42 , pp. 415-419
    • Kiemeney, L.A.1
  • 46
    • 0037051091 scopus 로고    scopus 로고
    • Familial aggregation of urothelial cell carcinoma
    • Aben, K. K. et al. Familial aggregation of urothelial cell carcinoma. Int. J. Cancer 98, 274-278 (2002).
    • (2002) Int. J. Cancer , vol.98 , pp. 274-278
    • Aben, K.K.1
  • 47
    • 0035913187 scopus 로고    scopus 로고
    • Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours
    • Sibley, K., Stern, P & Knowles, M. A. Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours. Oncogene 20, 4416-4418 (2001).
    • (2001) Oncogene , vol.20 , pp. 4416-4418
    • Sibley, K.1    Stern, P.2    Knowles, M.A.3
  • 48
    • 0035825598 scopus 로고    scopus 로고
    • Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cel carcinoma
    • Sibley, K., Cuthbert-Heavens, D. & Knowles, M. A. Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cel carcinoma. Oncogene 20, 686-691 (2001).
    • (2001) Oncogene , vol.20 , pp. 686-691
    • Sibley, K.1    Cuthbert-Heavens, D.2    Knowles, M.A.3
  • 49
    • 33747079040 scopus 로고    scopus 로고
    • Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas
    • Hernández, S. et al. Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. J. Clin. Oncol. 24, 3664-3671 (2006).
    • (2006) J. Clin. Oncol. , vol.24 , pp. 3664-3671
    • Hernández, S.1
  • 50
    • 19744367140 scopus 로고    scopus 로고
    • Urine markers for bladder cancer surveillance: A systematic review
    • Van Rhijn, B. W., Van der Poel, H. G. & Van der Kwast, T H. Urine markers for bladder cancer surveillance: a systematic review. Eur. Urol. 47, 736-748 (2005).
    • (2005) Eur. Urol. , vol.47 , pp. 736-748
    • Van Rhijn, B.W.1    Van Der Poel, H.G.2    Van Der Kwast, T.H.3
  • 51
    • 75949121210 scopus 로고    scopus 로고
    • Molecular screening for bladder cancer: Progress and potential
    • Mitra, A. P & Cote, R. J. Molecular screening for bladder cancer: progress and potential. Nat Rev. Urol. 7, 11-20 (2010).
    • (2010) Nat Rev. Urol. , vol.7 , pp. 11-20
    • Mitra, A.P.1    Cote, R.J.2
  • 52
    • 62149132464 scopus 로고    scopus 로고
    • Molecular markers for detection, surveillance and prognostication of bladder cancer
    • Vrooman, O. P & Witjes, J. A. Molecular markers for detection, surveillance and prognostication of bladder cancer. Int. J. Urol. 16, 234-243 (2009).
    • (2009) Int. J. Urol. , vol.16 , pp. 234-243
    • Vrooman, O.P.1    Witjes, J.A.2
  • 53
    • 0003809054 scopus 로고    scopus 로고
    • Springer-Verlag, New York
    • th edn (Springer-Verlag, New York, 2002).
    • (2002) th Edn
    • Greene, F.L.1
  • 56
    • 0031740494 scopus 로고    scopus 로고
    • The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee
    • Epstein, J. I., Amin, M. B., Reuter, V. R. & Mostofi, F K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol. 22, 1435-1448 (1998).
    • (1998) Am. J. Surg. Pathol. , vol.22 , pp. 1435-1448
    • Epstein, J.I.1    Amin, M.B.2    Reuter, V.R.3    Mostofi, F.K.4
  • 57
    • 33847095882 scopus 로고    scopus 로고
    • Histologic grading of noninvasive papillary urothelial neoplasms
    • MacLennan, G. T., Kirkali, Z. & Cheng, L. Histologic grading of noninvasive papillary urothelial neoplasms. Eur. Urol. 51, 889-898 (2007).
    • (2007) Eur. Urol. , vol.51 , pp. 889-898
    • MacLennan, G.T.1    Kirkali, Z.2    Cheng, L.3
  • 58
    • 0036718575 scopus 로고    scopus 로고
    • Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: Practical choices for patient care
    • Murphy, W. M., Takezawa, K. & Maruniak, N. A. Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care. J. Urol. 168, 968-972 (2002).
    • (2002) J. Urol. , vol.168 , pp. 968-972
    • Murphy, W.M.1    Takezawa, K.2    Maruniak, N.A.3
  • 59
    • 77949491713 scopus 로고    scopus 로고
    • Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: A multicentre study comparing the 1973 and 2004 world health organisation classifications
    • May, M. et al. Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 world health organisation classifications. Eur. Urol. 57, 850-858 (2010).
    • (2010) Eur. Urol. , vol.57 , pp. 850-858
    • May, M.1
  • 60
    • 77951622842 scopus 로고    scopus 로고
    • The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading
    • Rhijn, B. W. et al. The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading. Eur. Urol. 57, 1052-1057 (2010).
    • (2010) Eur. Urol. , vol.57 , pp. 1052-1057
    • Rhijn, B.W.1
  • 61
    • 33751418969 scopus 로고    scopus 로고
    • Discrepancy between clinical and pathologic stage: Impact on prognosis after radical cystectomy
    • Shariat, S. F. et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur. Urol. 51, 137-151 (2007).
    • (2007) Eur. Urol. , vol.51 , pp. 137-151
    • Shariat, S.F.1
  • 62
    • 77549086840 scopus 로고    scopus 로고
    • Staging and staging errors in bladder cancer
    • Bostrom, P J. et al. Staging and staging errors in bladder cancer. Eur. Urol. Suppl. 9, 2-9 (2010).
    • (2010) Eur. Urol. Suppl. , vol.9 , pp. 2-9
    • Bostrom, P.J.1
  • 63
    • 0033786654 scopus 로고    scopus 로고
    • The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: A combined analysis of 5 European organization for research and treatment of cancer trials
    • Van Der Meijden, A., Sylvester, R., Collette, L., Bono, A. & Ten Kate, F. The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European organization for research and treatment of cancer trials. J. Urol. 164, 1533-1537 (2000).
    • (2000) J. Urol. , vol.164 , pp. 1533-1537
    • Van Der Meijden, A.1    Sylvester, R.2    Collette, L.3    Bono, A.4    Ten Kate, F.5
  • 64
    • 0028049182 scopus 로고
    • The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial
    • Members of the Dutch South East Cooperative Urological Group
    • Witjes, J. A., Kiemeney, L. A., Schaafsma, H. E. & Debruyne, F. M. The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Members of the Dutch South East Cooperative Urological Group. Br. J. Urol. 73, 172-176 (1994).
    • (1994) Br. J. Urol. , vol.73 , pp. 172-176
    • Witjes, J.A.1    Kiemeney, L.A.2    Schaafsma, H.E.3    Debruyne, F.M.4
  • 65
    • 33645970703 scopus 로고    scopus 로고
    • Review pathology in a diagnostic bladder cancer trial: Effect of patient risk category
    • Witjes, J. A., Moonen, P M. J. & van der Heijden, A. G. Review pathology in a diagnostic bladder cancer trial: effect of patient risk category. Urology 67, 751-755 (2006).
    • (2006) Urology , vol.67 , pp. 751-755
    • Witjes, J.A.1    Moonen, P.M.J.2    Van Der Heijden, A.G.3
  • 66
    • 70350462404 scopus 로고    scopus 로고
    • Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: The CUETO scoring model
    • Fernandez-Gomez, J. et al. Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. J. Urol. 182, 2195-2203 (2009).
    • (2009) J. Urol. , vol.182 , pp. 2195-2203
    • Fernandez-Gomez, J.1
  • 67
    • 0036586644 scopus 로고    scopus 로고
    • Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies
    • Brausi, M. et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur. Urol. 41, 523-531 (2002).
    • (2002) Eur. Urol. , vol.41 , pp. 523-531
    • Brausi, M.1
  • 68
    • 34250303107 scopus 로고    scopus 로고
    • A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer
    • Grossman, H. B. et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J. Urol. 178, 62-67 (2007).
    • (2007) J. Urol. , vol.178 , pp. 62-67
    • Grossman, H.B.1
  • 69
    • 0028551697 scopus 로고
    • Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid
    • Kriegmair, M. et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 44, 836-841 (1994).
    • (1994) Urology , vol.44 , pp. 836-841
    • Kriegmair, M.1
  • 70
    • 0035097699 scopus 로고    scopus 로고
    • Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer
    • Riedl, C. R. et al. Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J. Urol. 165, 1121-1123 (2001).
    • (2001) J. Urol. , vol.165 , pp. 1121-1123
    • Riedl, C.R.1
  • 71
    • 0346848832 scopus 로고    scopus 로고
    • Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy
    • Schmidbauer, J. et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy J. Urol. 171, 135-138 (2004).
    • (2004) J Urol. , vol.171 , pp. 135-138
    • Schmidbauer, J.1
  • 72
    • 77249090657 scopus 로고    scopus 로고
    • Photodynamic diagnosis in non-muscle-invasive bladder cancer: A systematic review and cumulative analysis of prospective studies
    • Kausch, I. et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur. Urol. 57, 595-606 (2010).
    • (2010) Eur. Urol. , vol.57 , pp. 595-606
    • Kausch, I.1
  • 73
    • 0032874440 scopus 로고    scopus 로고
    • The value of a second transurethral resection in evaluating patients with bladder tumors
    • Herr, H. W. The value of a second transurethral resection in evaluating patients with bladder tumors. J. Urol. 162, 74-76 (1999).
    • (1999) J. Urol. , vol.162 , pp. 74-76
    • Herr, H.W.1
  • 74
    • 0038152768 scopus 로고    scopus 로고
    • Effect of routine repeat transurethral resection for superficial bladder cancer: A long-term observational study
    • Grimm, M. O. et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J. Urol. 170, 433-437 (2003).
    • (2003) J. Urol. , vol.170 , pp. 433-437
    • Grimm, M.O.1
  • 75
    • 33646100303 scopus 로고    scopus 로고
    • The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: A prospective, randomized clinical trial
    • Divrik, R. T., Yildirim, U., Zorlu, F. & Ozen, H. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J. Urol. 175, 1641-1644 (2006).
    • (2006) J. Urol. , vol.175 , pp. 1641-1644
    • Divrik, R.T.1    Yildirim, U.2    Zorlu, F.3    Ozen, H.4
  • 76
    • 2442581163 scopus 로고    scopus 로고
    • P A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials
    • Sylvester, R. J., Oosterlinck, W. & van der Meijden, A. P A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials. J. Urol. 171, 2186-2190 (2004).
    • (2004) J. Urol. , vol.171 , pp. 2186-2190
    • Sylvester, R.J.1    Oosterlinck, W.2    Van Der Meijden, A.3
  • 77
    • 67651008250 scopus 로고    scopus 로고
    • Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: A randomised, double-blind, placebo-controlled phase III multicentre study
    • Böhle, A. et al. Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study. Eur. Urol. 56, 495-503 (2009).
    • (2009) Eur. Urol. , vol.56 , pp. 495-503
    • Böhle, A.1
  • 78
    • 36849046271 scopus 로고    scopus 로고
    • A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences
    • Berrum-Svennung, I., Granfors, T, Jahnson, S., Boman, H. & Holmäng, S. A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences. J. Urol. 179, 101-105 (2008).
    • (2008) J. Urol. , vol.179 , pp. 101-105
    • Berrum-Svennung, I.1    Granfors, T.2    Jahnson, S.3    Boman, H.4    Holmäng, S.5
  • 80
    • 41149134455 scopus 로고    scopus 로고
    • Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer
    • Hendricksen, K. et al. Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer. Eur. Urol. 53, 984-991 (2008).
    • (2008) Eur. Urol. , vol.53 , pp. 984-991
    • Hendricksen, K.1
  • 81
    • 44649193794 scopus 로고    scopus 로고
    • Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study
    • Cai, T. et al. Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study. J. Urol. 180, 110-115 (2008).
    • (2008) J. Urol. , vol.180 , pp. 110-115
    • Cai, T.1
  • 82
    • 67649226588 scopus 로고    scopus 로고
    • Treatment of nonmuscle invading bladder cancer: Do physicians in the United States practice evidence based medicine? the use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors
    • Madeb, R. et al. Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors. Cancer 115, 2660-2670 (2009).
    • (2009) Cancer , vol.115 , pp. 2660-2670
    • Madeb, R.1
  • 83
    • 77957706659 scopus 로고    scopus 로고
    • Contemporary cost analysis of single instillation of mitomycin after transurethral resection of bladder tumor in a universal health care system
    • Feifer, A., Xie, X., Brophy, J. M., Segal, R. & Kassouf, W. Contemporary cost analysis of single instillation of mitomycin after transurethral resection of bladder tumor in a universal health care system. Urology 76, 652-656 (2010).
    • (2010) Urology , vol.76 , pp. 652-656
    • Feifer, A.1    Xie, X.2    Brophy, J.M.3    Segal, R.4    Kassouf, W.5
  • 84
    • 0036668380 scopus 로고    scopus 로고
    • Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma
    • Kaasinen, E. et al. Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma. Eur. Urol. 42, 167-174 (2002).
    • (2002) Eur. Urol. , vol.42 , pp. 167-174
    • Kaasinen, E.1
  • 85
    • 0033888947 scopus 로고    scopus 로고
    • The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer
    • Solsona, E. et al. The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer. J. Urol. 164, 685-689 (2000).
    • (2000) J. Urol. , vol.164 , pp. 685-689
    • Solsona, E.1
  • 86
    • 0036128238 scopus 로고    scopus 로고
    • Stage Ta-T1 bladder cancer: The relationship between findings at first followup cystoscopy and subsequent recurrence and progression
    • Holmang, S. & Johansson, S. L. Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression. J. Urol. 167, 1634-1637 (2002).
    • (2002) J. Urol. , vol.167 , pp. 1634-1637
    • Holmang, S.1    Johansson, S.L.2
  • 87
    • 15044358608 scopus 로고    scopus 로고
    • A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database
    • Mariappan, P. & Smith, G. A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database. J. Urol. 173, 1108-1111 (2005).
    • (2005) J. Urol. , vol.173 , pp. 1108-1111
    • Mariappan, P.1    Smith, G.2
  • 88
    • 33644783750 scopus 로고    scopus 로고
    • The management of superficial transitional cell carcinoma of the bladder
    • Sengupta, S. & Blute, M. L. The management of superficial transitional cell carcinoma of the bladder. Urology 67, 48-54 (2006).
    • (2006) Urology , vol.67 , pp. 48-54
    • Sengupta, S.1    Blute, M.L.2
  • 89
    • 0038152765 scopus 로고    scopus 로고
    • Expectant management of small, recurrent, noninvasive papillary bladder tumors
    • Soloway, M. S., Bruck, D. S. & Kim, S. S. Expectant management of small, recurrent, noninvasive papillary bladder tumors. J. Urol. 170, 438-441 (2003).
    • (2003) J. Urol. , vol.170 , pp. 438-441
    • Soloway, M.S.1    Bruck, D.S.2    Kim, S.S.3
  • 90
    • 32044434005 scopus 로고    scopus 로고
    • Watchful waiting policy in recurrent Ta G1 bladder tumors
    • Gofrit, O. N., Pode, D., Lazar, A., Katz, R. & Shapiro, A. Watchful waiting policy in recurrent Ta G1 bladder tumors. Eur. Urol. 49, 303-307 (2006).
    • (2006) Eur. Urol. , vol.49 , pp. 303-307
    • Gofrit, O.N.1    Pode, D.2    Lazar, A.3    Katz, R.4    Shapiro, A.5
  • 91
    • 70449526272 scopus 로고    scopus 로고
    • Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles
    • Birkhahn, M. et al. Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles. Eur. Urol. 57, 12-20 (2010).
    • (2010) Eur. Urol. , vol.57 , pp. 12-20
    • Birkhahn, M.1
  • 92
    • 77951981568 scopus 로고    scopus 로고
    • Theranostic and prognostic biomarkers: Genomic applications in urological malignancies
    • Netto, G. J. & Epstein, J. I. Theranostic and prognostic biomarkers: genomic applications in urological malignancies. Pathology 42, 384-394 (2010).
    • (2010) Pathology , vol.42 , pp. 384-394
    • Netto, G.J.1    Epstein, J.I.2
  • 93
    • 39449116677 scopus 로고    scopus 로고
    • Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder
    • Bryan, R. T., Billingham, L. J. & Wallace, D. M. Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int. 101, 702-705 (2008).
    • (2008) BJU Int. , vol.101 , pp. 702-705
    • Bryan, R.T.1    Billingham, L.J.2    Wallace, D.M.3
  • 94
    • 53849134494 scopus 로고    scopus 로고
    • A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences
    • Herr, H. W. & Donat, S. M. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU Int. 102, 1111-1114 (2008).
    • (2008) BJU Int. , vol.102 , pp. 1111-1114
    • Herr, H.W.1    Donat, S.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.